Zacks Investment Research on MSN
Dexcom's G7 shows strong results in type 2 diabetes CONNECT study
DexCom, Inc. DXCM recently announced that results from its CONNECT randomized controlled trial have been published in The New England Journal of Medicine. The study evaluated the benefits of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results